Orlando, FL (PRWEB) April 12, 2007
At the Institute for International Research (IIR) 16th Annual Partnership with CROs Conference today, ClearTrial announced the release of ClearTrial 2.1, an enhanced version of the company's popular clinical trial software that helps biopharmaceutical companies and clinical research organizations (CROs) work more effectively to plan, budget, outsource and optimize the operational design of clinical trials.
New features include enhanced support for the European Union (EU) Directive, with ClearTrial 2.1 providing even more flexibility to control site-activation delay factors related to regulatory approval. Another flexibility enhancement allows users to specify multiple monitoring frequencies over the life of the study.
A major enhancement includes support for endpoint studies, which include many oncology studies, compassionate use studies and event-driven studies where the treatment period continues for all subjects until a defined number of events occurs. "It has always been difficult to accurately cost endpoint studies with sensitivity to the CRF data created during extended treatment periods for subjects who enter studies in earlier stages," says Michael Soenen, Managing Partner of ClearTrial. "ClearTrial 2.1 now makes it very fast to model multiple possible scenarios for anticipated endpoint dates."
Other new features include enhancements to the monthly budget report that show activity-based fees and pass-through costs over the life of the study, more granular control to specify staff-levels assigned to monitoring and more versatile pass-through and miscellaneous cost management.
ClearTrial customers who have had an advanced look praise the new version. "I am very impressed with how complete and flexible the ClearTrial software is. It lets us very quickly produce everything from annual, long-range budgets, to detailed RFP documents, for any outsourcing model we opt to use," said a Senior Director, Clinical Operations at a major west coast Biotech.
ClearTrial® is a leading provider of clinical trial software for clinical operations planning, budgeting and outsourcing. ClearTrial's software helps pharmaceutical, biotechnology, medical device companies and CROs expedite the clinical development process without sacrificing quality of results. The company's software products support clinical operations, resource planning and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit http://www.cleartrial.com.
ClearTrial®, ClearTrial® Plan, ClearTrial® Source, and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Other product names mentioned in this release are hereby acknowledged as registered trademarks of their respective owners.